- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharma has received USFDA Final Approval for its Paroxetine Extended-Release Tablets (25 mg and 37.5 mg). This approval for a drug treating depression and anxiety disorders enhances its US generic portfolio.